CDKN1A: a double-edged sword in fatty liver?
Department of Pathophysiology and Transplantation; Università degli Studi di Milano; Milan, Italy; Internal Medicine; Fondazione IRCCS Ca' Granda Ospedale Policlinico Milano; Milan, Italy.
Luca
L
Valenti
Internal Medicine; Fondazione IRCCS Ca' Granda Ospedale Policlinico Milano; Milan, Italy.
Paola
P
Dongiovanni
D016922:Cellular Senescence; D050759:Cyclin-Dependent Kinase Inhibitor p21 / Q000378:metabolism*; D005260:Female; D006801:Humans; D008297:Male; D065626:Non-alcoholic Fatty Liver Disease / Q000378:metabolism*
D050759:Cyclin-Dependent Kinase Inhibitor p21
CDKN1A; genetics; hepatic fibrosis; hepatic stellate cells; nonalcoholic fatty liver disease; p21; senescence; steatohepatits